![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 11, 8524-8534, March 16, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Pathology, Mount Sinai School of Medicine,
New York, New York 10029
The E2A gene products, E12 and E47, are
multifunctional transcription factors that as homodimers regulate B
cell development, growth, and survival. In this report, the E2A gene
products are shown to be targets for regulation by the
G1 cyclin-dependent kinases. Two novel
G1 cyclin-dependent kinase sites are identified on the N-terminal domain of E12/E47. One site displays homology to a
preferential D-type cyclin-dependent kinase site (serine 780) on the retinoblastoma susceptibility gene product (pRB) and, consistent with this homology, is more efficiently phosphorylated by
cyclin D1-CDK4 than by the other cyclin-dependent kinases
(CDK) that were tested. The second kinase site is phosphorylated by both cyclin D1-CDK4 and cyclin A/E-CDK2 complexes. Mutation studies indicated that phosphorylation of the cyclin D1-CDK4 site, or more
potently, of both the cyclin D1-CDK4 and cyclin A/E-CDK2 sites,
negatively regulates the growth suppressor function associated with the
N-terminal domain of E12/E47. Transient expression studies showed that
ectopic expression of cyclin D1 or E negatively regulates sequence-specific activation of gene transcription by E12/E47. Analysis
of site mutants, however, indicated that inhibition of E12/E47
transcriptional activity did not require the N-terminal G1
cyclin-dependent kinase sites. Together, the results
suggest that the growth suppressor and transcriptional activator
functions of E12/E47 are targets for regulation by G1
cyclin-dependent kinases but that the mechanisms of
regulation for each function are distinct.
Identification of the E2A Gene Products as Regulatory Targets
of the G1 Cyclin-dependent Kinases*
*
This work was supported by United States Public Health
Service Grant CA-72775 from the NCI of the National Institutes of
Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Pathology
(1194), Mount Sinai School of Medicine, 1 Gustave Levy Place, New York,
NY 10029. Tel.: 212-241-9169; Fax: 212-534-7491; E-mail: stave.kohtz@mssm.edu.
This article has been cited by other articles:
![]() |
D. Frasca, E. Van der Put, A. M. Landin, D. Gong, R. L. Riley, and B. B. Blomberg RNA Stability of the E2A-Encoded Transcription Factor E47 Is Lower in Splenic Activated B Cells from Aged Mice J. Immunol., November 15, 2005; 175(10): 6633 - 6644. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Van der Put, D. Frasca, A. M. King, B. B. Blomberg, and R. L. Riley Decreased E47 in Senescent B Cell Precursors Is Stage Specific and Regulated Posttranslationally by Protein Turnover J. Immunol., July 15, 2004; 173(2): 818 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Frasca, D. Nguyen, R. L. Riley, and B. B. Blomberg Decreased E12 and/or E47 Transcription Factor Activity in the Bone Marrow As Well As in the Spleen of Aged Mice J. Immunol., January 15, 2003; 170(2): 719 - 726. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |